A seasonality-adjusted sequential test for vaccine safety surveillance
From MaRDI portal
Publication:6589304
DOI10.1111/BIOM.13829zbMATH Open1543.62638MaRDI QIDQ6589304FDOQ6589304
Authors: Rex Shen, Keran Moll, Ying Lu, Lu Tian
Publication date: 19 August 2024
Published in: Biometrics (Search for Journal in Brave)
Cites Work
- A maximized sequential probability ratio test for drug and vaccine safety surveillance
- Nearly optimal sequential tests of composite hypotheses
- A sequential likelihood ratio test for general hypotheses
- Title not available (Why is that?)
- Stepwise Likelihood Ratio Statistics in Sequential Studies
- Title not available (Why is that?)
- Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
- Continuous post-market sequential safety surveillance with minimum events to signal
- Exact conditional maximized sequential probability ratio test adjusted for covariates
- Alpha spending for historical versus surveillance Poisson data with CMaxSPRT
- Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data
This page was built for publication: A seasonality-adjusted sequential test for vaccine safety surveillance
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6589304)